| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8210795 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 16 Pages |
Abstract
The number of choline-avid metastases was a significant prognostic factor for progression after [18F]-fluormethylcholine PET/CT-guided SBRT for recurrent oligometastatic prostate cancer, and there seemed to be a trend in risk of progression for patients with large MATVs. The lesional level of [18F]-fluoromethylcholine uptake was not prognostic for progression.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
![Prognostic Value of [18F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer](/preview/png/8210795.png "First Page Preview: Prognostic Value of [18F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer")
Authors
Matthijs BSc, Esther MD, Otto MD, PhD, Alfons MD, PhD, Maartje MD, Jeroen MD, PhD, Ronald PhD, Max MD, PhD, Daniela MD, PhD,